Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewAIDS/HIVImmunologyInfectious disease Open Access | 10.1172/jci.insight.201268

The pleural tuberculosis-associated microenvironment promotes HIV-1 persistence by impairing CD8+ T cell-mediated viral control

Samantha Cronin,1 Jennifer Simpson,1 Andrea Pereyra-Casanova,1 Yuchen Li,1 Josefina Marín-Rojas,2 Freja A. Warner van Dijk,1 Katie Fisher,1 Daniel J. Buffa,1 Hafsa Rana,1 Zoï Vahlas,3 Joaquina Barros,4 Mariano Maio,4 Thomas R. O'Neil,1 Kirstie M. Bertram,1 Eunok Lee,1 Najla Nasr,1 Andrew N. Harman,1 Gabriela Turk,4 Maria Florencia Quiroga,4 Anthony D. Kelleher,7 Christel Vérollet,8 Luciana Balboa,4 Sarah Palmer,1 and Gabriel Duette1

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Cronin, S. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Simpson, J. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Pereyra-Casanova, A. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Li, Y. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Marín-Rojas, J. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Warner van Dijk, F. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Fisher, K. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Buffa, D. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Rana, H. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Vahlas, Z. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Barros, J. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Maio, M. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by O'Neil, T. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Bertram, K. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Lee, E. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Nasr, N. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Harman, A. in: PubMed | Google Scholar |

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Turk, G. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Quiroga, M. in: PubMed | Google Scholar |

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Kelleher, A. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Vérollet, C. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Balboa, L. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Palmer, S. in: PubMed | Google Scholar

1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia

2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia

3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France

4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina

5Centre for Virus Research, The Westmead Institute for Medical Research, Australia

6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia

7The Kirby Institute, University of New South Wales, Sydney, Australia

8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France

Find articles by Duette, G. in: PubMed | Google Scholar |

Published August 20, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.201268.
Copyright © 2026, Cronin et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published August 20, 2026 - Version history
View PDF
Abstract

Mycobacteriumtuberculosis (Mtb), the causative agent of tuberculosis (TB), is the most common coinfection in people living with HIV-1 (PLWH). This coinfection is associated with accelerated HIV-1 disease progression and reduced survival. However, the immunological and virological mechanisms driving this progression are not completely understood. To address this knowledge gap, using pleural effusion samples from PLWH and TB, we investigated how the HIV-1 genetic landscape and the anti-HIV-1 immune response are impacted by a TB-associated microenvironment. Our results revealed an enrichment of genetically intact HIV-1 and impaired CD8+ T cell-mediated antiviral response at this site of HIV-1/Mtb coinfection. Moreover, efficient CD8+ T cell activation was inhibited by lipids present in the TB-associated pleural effusion. These findings indicate that this immune microenvironment induced by TB promotes the persistence of cells infected with replication-competent HIV-1 by creating a niche of reduced antiviral immune pressure, potentially contributing to the worsened clinical outcomes observed in PLWH and TB.

Supplemental material

View

Version history
  • Version 1 (August 20, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts